Cardiovascular Systems Accounts Payable

Cardiovascular Systems (CSII) currently reports a accounts payable of $17M as of December 2022. That compares with $12M in the prior-year period — up 36.8% year over year. Use the charts on this page to explore Cardiovascular Systems's accounts payable history and peer comparisons.

Cardiovascular Systems's accounts payable increased from $12M to $17M — a 36.8% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cardiovascular Systems reported $17M in accounts payable as of December 2022. That compares with $12M in the prior-year period — up 36.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $17M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cardiovascular Systems, and consider following CSII for alerts when major investors trade the stock.

Cardiovascular Systems is classified in the Healthcare sector. On accounts payable, it currently shows $17M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CSII with unrelated industries.